Why Eli Lilly Is a No-Brainer Stock to Buy on the Dip

The market overreacted to Lilly's Q3 earnings miss and full-year guidance cut. High-flying aircraft experience turbulence from time to time. It's the same story with stocks. We saw that happen with Eli Lilly (LLY -2.02%) this week. Lilly announced its third-quarter results on Wednesday. Investors didn't like what they heard. The big pharma stock initially plunged close to 15% after the market opened on Thursday before bouncing back somewhat. Even with this partial rebound, Lilly's share price remains roughl ...